19038502

Source:http://linkedlifedata.com/resource/pubmed/id/19038502

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002844, umls-concept:C0011860, umls-concept:C0025598, umls-concept:C0028754, umls-concept:C0205263, umls-concept:C0871712, umls-concept:C0948265, umls-concept:C1708528
pubmed:issue	2
pubmed:dateCreated	2008-12-29
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7505668
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Metformin
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0306-9877
pubmed:author	pubmed-author:CohenPaulP
pubmed:issnType	Print
pubmed:volume	72
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	227-8
pubmed:meshHeading	pubmed-meshheading:19038502-Androgen Antagonists, pubmed-meshheading:19038502-Diabetes Mellitus, Type 2, pubmed-meshheading:19038502-Humans, pubmed-meshheading:19038502-Male, pubmed-meshheading:19038502-Metabolic Syndrome X, pubmed-meshheading:19038502-Metformin, pubmed-meshheading:19038502-Obesity, pubmed-meshheading:19038502-Prostatic Neoplasms
pubmed:year	2009
pubmed:articleTitle	Metformin for the prevention of androgen deprivation induced metabolic syndrome, obesity and type 2 diabetes.
pubmed:publicationType	Letter